Share

Mouse models of myelofibrosis

Project objectives

The aim of this project is to use the Gata1low mouse model to identify in detail the patho-biological mechanism that determines the mobilization of stem/progenitor cells and extramedullary hematopoiesis in primary myelofibrosis.

Start and end date

May 2023 - May 2028

Project Manager

prof Maria Zingarielloariello

Coordinating institution of the project

MSSM

Other institutions involved in the project

  • Anna Rita Franco Migliaccio, Lecce, Italy
  • John A. Stamatoyannopoulos, Altius Institute for Biomedical Sciences, Seattle, WA, USA
  • John Crispino, St. Jude Children's Research Hospital, Memphis, TN, USA
  • Ronald Hoffman, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • John Mascarenhas, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • Ross Levine, Memorial Sloan Kettering Cancer Center New York, NY

Funding source(s).

National Cancer Institute CA108671-11-16 MPD Research Consortium, PI Ronald Hoffman
magnifiercrossmenuchevron-downchevron-leftchevron-right